Vertex Pharmaceuticals | Capital Ordinaire

Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2023-09
Acadia Pharmaceuticals USD 16K 0 2023-12
Agios Pharmaceuticals USD 72K 0 2023-12
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Amgen USD 32.75B 152M 2023-09
Arrowhead Research USD 200K 0 2023-12
Gilead Sciences USD 1000K 0 2023-09
Incyte USD 224K 0 2023-12
Insmed USD 1.48M 50K 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Moderna USD 38.2K 100 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
Pfizer USD 478M 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Roche Holding CHF 107M 0 2023-06
Sarepta Therapeutics USD 9K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
United Therapeutics USD 700K 0 2023-12
Vertex Pharmaceuticals USD 2.6M 0 2023-09



Vertex Pharmaceuticals Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.